Literature DB >> 15717657

Exacerbations of Graves' disease after unilateral adrenalectomy for Cushing's syndrome.

E Arikan1, S Guldiken, B Ugur Altun, M Kara, A Tugrul.   

Abstract

Cushing's syndrome is characterized by endogenously increased production of glucocorticoids. The activity of immune system is regulated mainly by two systems in the body. Glucocorticoids and NF-kappaB counteract the effects of each other on the immune system. It has been reported that immune response is exaggerated after the amelioration of Cushing's syndrome. We report a rare case of exacerbation of Graves' disease after unilateral adrenalectomy for Cusing's syndrome. A 50-yr-obese woman with hypertension, dyslipidemia, impaired glucose tolerance and insulin resistance wasadmitted to outpatients clinic of endocrinology. The results of evaluation of glucocorticoids metabolism and adrenal magnetic resonance imaging revealed the Cusing's syndrome. We also assessed thyroid function tests because of the diagnosis of goiter and thyroid hormone replacement in her medical history, and the presence of exophthalmia and tachycardia in examination. Althoug TSH level was detected at the lower border of normal range, free T4 and free T3 were in normal range and autoantibody of thyroidal peroxidase and thyroglobulin was higer than normal reference range. An operation was performed and a mass was removed from her left adrenal gland. The pathologic examination confirmed adrenal adenoma. She was re-admitted to the outpatient clinic 9 months after with complaints of palpitation, malaise and weight loss. Tests carried out to determine the thyroid function revealed Graves' disease. We prescribed propylthiouracil and beta-blocker treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15717657     DOI: 10.1007/BF03347482

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

Review 1.  Cushing's syndrome.

Authors:  M Boscaro; L Barzon; F Fallo; N Sonino
Journal:  Lancet       Date:  2001-03-10       Impact factor: 79.321

Review 2.  Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways.

Authors:  L I McKay; J A Cidlowski
Journal:  Endocr Rev       Date:  1999-08       Impact factor: 19.871

3.  Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease.

Authors:  A Colao; R Pivonello; A Faggiano; M Filippella; D Ferone; C Di Somma; G Cerbone; P Marzullo; G Fenzi; G Lombardi
Journal:  Clin Endocrinol (Oxf)       Date:  2000-07       Impact factor: 3.478

4.  Polymyalgia rheumatica presenting after successful treatment of Cushing's disease.

Authors:  S I Muzulu; T A Howlett
Journal:  Br J Rheumatol       Date:  1998-07

5.  Systemic lupus erythematosus after pituitary adenomectomy in a patient with Cushing's disease.

Authors:  Y Noguchi; H Tamai; K Fujisawa; J Nagano; T Mukuta; G Komaki; S Masubayashi; C Kubo; M Torisu; H Nakagaki; S Imayama
Journal:  Clin Endocrinol (Oxf)       Date:  1998-05       Impact factor: 3.478

6.  Transient Graves disease developing after surgery for Cushing disease.

Authors:  Hiroyuki Morita; Mako Isaji; Tomoatsu Mune; Hisashi Daido; Yukinori Isomura; Hiroshi Sarui; Tetsuya Tanahashi; Noriyuki Takeda; Tatsuo Ishizuka; Keigo Yasuda
Journal:  Am J Med Sci       Date:  2002-03       Impact factor: 2.378

7.  The role of glucocorticoids in the regulation of thyrotropin.

Authors:  A Brabant; G Brabant; T Schuermeyer; U Ranft; F W Schmidt; R D Hesch; A von zur Mühlen
Journal:  Acta Endocrinol (Copenh)       Date:  1989-07

8.  TSH secretion in Cushing's syndrome: relation to glucocorticoid excess, diabetes, goitre, and the 'sick euthyroid syndrome'.

Authors:  G Benker; M Raida; T Olbricht; R Wagner; W Reinhardt; D Reinwein
Journal:  Clin Endocrinol (Oxf)       Date:  1990-12       Impact factor: 3.478

9.  Exacerbation of autoimmune thyroid dysfunction after unilateral adrenalectomy in patients with Cushing's syndrome due to an adrenocortical adenoma.

Authors:  N Takasu; I Komiya; Y Nagasawa; T Asawa; T Yamada
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

10.  Exacerbation of rheumatoid arthritis after removal of adrenal adenoma in Cushing's syndrome.

Authors:  F Yakushiji; M Kita; N Hiroi; H Ueshiba; I Monma; Y Miyachi
Journal:  Endocr J       Date:  1995-04       Impact factor: 2.349

View more
  1 in total

1.  Graves' Disease after Adrenalectomy for Cushing's Syndrome.

Authors:  Yuji Hiromatsu; Hiroyuki Eguchi; Yui Nakamura; Kei Mukohara
Journal:  Intern Med       Date:  2020-09-05       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.